Name: 글로벌 시장 동향
SKU: CD874
Availability: InStock

보고서 요약(국문)

임상 검사실 서비스 시장 규모
글로벌 임상 검사실 서비스 시장은 2023년 225억 6천만 달러에 달했으며, 2024년부터 2031년까지 연평균 6.5%의 성장률을 기록하며 2031년에는 4,141억 8천만 달러에 이를 것으로 예상됩니다.
임상 검사실은 의료 산업의 필수적인 부분이며, 질병의 발견, 진단 및 치료에 중요한 역할을 합니다. 체액, 조직 및 세포를 검사하고 분석하기 위해 검체를 채취합니다. 검사실은 정확한 결과를 제공하여 의사가 적절한 치료 결정을 내릴 수 있도록 지원합니다. 또한 의사는 검사 결과를 바탕으로 치료 과정을 시작/중단하거나 계속할 수 있으며, 의료 결정의 70%는 검사실 결과에 기반합니다. 검사실 기관들은 검사 시간 단축과 효율성 증대를 위해 제품 개선에 집중하고 있으며, 이는 임상 검사실 관리의 효율성을 높이고 있습니다.

임상 검사실 서비스 시장 동향
임상 검사실 서비스에 대한 수요 증가, 후두암 발병률 증가, 연구 개발 지출 증가 및 신제품 출시 증가가 시장 성장을 견인할 것으로 예상됩니다.
신제품 출시 증가와 임상 검사실 서비스 수요 증가는 시장 성장을 촉진할 것입니다.
전 세계 임상 검사실 서비스 시장은 만성 질환 증가와 신제품 출시 증가로 인한 의료 산업의 임상 검사실 서비스 수요에 의해 주도되고 있습니다. 다양한 주요 분야에서 새로운 진단 검사법 및 임상 시험에 대한 연구가 진행되고 있습니다. 예를 들어, 진단 정보 서비스 제공업체인 Quest Diagnostics는 2022년 7월 원숭이두창 바이러스 감염 진단을 돕기 위해 자체 개발한 최신 분자 진단 검사를 발표했습니다. 또한, CDC의 오르토폭스바이러스 검사도 곧 출시할 예정입니다.
다양한 최신 기술 발전이 이루어지고 있으며, 새롭고 혁신적인 제품 및 서비스 출시가 증가함에 따라 수요가 높아지고 있습니다. 임상 검사실의 최신 혁신이 시장 성장을 주도하고 있습니다. 예를 들어, 2022년 9월 Qiagen은 장기 이식 관련 바이러스에 대한 NeuMoDx 분석 포트폴리오에 새로운 제품을 추가했다고 발표했습니다. 이 최신 분석법은 유럽 연합 및 기타 여러 국가에서 CE(체외 진단) 인증을 획득했습니다. 이 새로운 분석법은 인간 헤르페스 바이러스 6형과 엡스타인-바 바이러스를 식별하고 정량화하는 데 사용됩니다.
의료 서비스 제공업체가 직면한 높은 가격 압박은 시장 성장을 저해할 것입니다.
그러나 의료비 지불자와 의료 서비스 제공업체가 직면한 가격 압박과 데이터 보안 및 개인 정보 보호와 관련된 대중의 우려는 시장 발전을 저해할 수 있습니다.
COVID-19가 임상 검사실 서비스 시장에 미치는 영향 분석
팬데믹은 전 세계 재정 전망, 운영 및 위기 대응 전략에 긍정적인 영향을 미쳤습니다. COVID-19 발생은 의료 산업에 심각한 영향을 미쳤습니다. 임상 검사실 서비스는 호황을 누렸으며, 진단 부문이 가장 큰 이익을 얻었습니다. 의약품 연구 및 진단 목적으로 사용되기 때문에 테스트 키트 및 분석법에 대한 수요가 높습니다. 전 세계적으로 다양한 협력 및 합병이 이루어지고 있으며, 이는 시장 성장을 촉진하고 있습니다. 예를 들어, 2022년 10월 생명과학 기업인 랩코프(Labcorp)는 미국의 비영리 의료 시스템인 어센션(Ascension)과 장기적인 실험실 협력 관계를 구축하기 위한 거래를 최근 완료했다고 발표했습니다.
임상 실험실 서비스 시장 세분화 분석
임상 화학 부문은 예측 기간(2024-2031년) 동안 가장 빠른 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다.
임상 화학 검사 유형 부문은 전 세계 임상 실험실 서비스 시장에서 가장 큰 시장 점유율을 차지하고 있습니다. 임상 화학은 혈액 및 소변 샘플을 분석하여 효소학 및 독성학 관련 다양한 검사를 수행하는 분야입니다. 혈당, 호르몬, 혈장 내 효소 등 다양한 물질을 정량적으로 검사합니다. 심혈관 질환, 당뇨병, 간 질환, 신장 질환, 혈액 질환과 같은 질병의 발생률이 전 세계적으로 증가함에 따라 임상 화학 검사가 시장을 주도하고 있습니다. 세계보건기구(WHO)에 따르면 2021년 약 4억 2,200만 명이 당뇨병을 앓았고, 매년 약 150만 명이 사망했습니다. 또한 매년 1,700만 명이 감염성 질환으로 사망합니다. 혁신적이고 첨단적인 검사법의 개발은 시장 성장을 촉진하고 있습니다. 예를 들어, 로슈의 코바스 8000 모듈형 분석기 시리즈는 광범위한 체외 임상 화학 및 면역 화학 진단 검사를 위한 모듈 기반 솔루션인 혈청 검사 영역입니다. 이는 고처리량 실험실에 맞게 개발되었습니다.
임상 검사실 서비스 시장 지역별 점유율
북미는 전 세계 임상 검사실 서비스 시장에서 가장 큰 시장 점유율을 차지하고 있습니다.
북미가 전 세계 임상 검사실 서비스 시장을 주도하는 주요 요인은 기업 간 파트너십 및 협력 증가, 잘 구축된 의료 인프라, 가처분 소득 증가, 연구 개발 활동에 대한 투자 증가로 인한 임상 검사실 서비스 수요 증가입니다. 이러한 요인들이 북미의 검사량 증가에 기여하고 있습니다. 또한, 광범위한 환자 기반, 잘 구축된 의료 인프라, 증가하는 가처분 소득, 그리고 연구 개발 활동에 대한 높은 투자액은 북미 시장 점유율 성장에 기여하고 있습니다. 미국 암 협회는 2022년 미국에서 약 190만 건의 새로운 암 환자가 등록될 것으로 추정했으며, 이 중 609,360명이 암으로 사망할 것으로 예상했습니다.
또한, 제품 출시 건수 증가도 시장 성장의 주요 요인입니다. GDP 대비 의료비 지출 비율이 높은 점 등 다른 요인들도 시장 성장을 촉진합니다. 많은 주요 개발 및 기술 발전이 이 지역에서 이루어지고 있습니다. 예를 들어, 2022년 1월 Exact Sciences는 환자들에게 유전자 암 검사의 접근성을 확대하기 위해 Prevention Genetics를 인수한다고 발표했습니다.
임상 검사실 서비스 기업 및 경쟁 환경
임상 검사실 서비스 시장은 국내외 기업들 간의 경쟁이 매우 치열합니다. 애보트 연구소(Abbott Laboratories), 바이오 레퍼런스 연구소(Bio Reference Laboratories), 이그젝트 사이언스(Exact Sciences Corporation), 마이리아드 제네틱스(Myriad Genetics, Inc), 네오게노믹스(Neogenomics Inc), 퀘스트 다이애그노스틱스(Quest Diagnostics Inc), 지멘스 헬스케어(Siemens Healthineer), 소닉 헬스케어(Sonic Healthcare Limited), 랩 코퍼레이션 오브 아메리카(Laboratory Corporation of America), 신랩 인터내셔널(Synlab International GmbH) 등이 주요 기업입니다. 이들 기업은 신제품 출시, 인수합병, 파트너십, 협력 등 다양한 성장 전략을 통해 시장 성장에 기여하고 있습니다. 예를 들어, 진단 정보 서비스 제공업체인 퀘스트 다이애그노스틱스는 2022년 10월, 섬마 헬스(Summa Health)의 실험실 서비스 사업 부문인 랩케어 플러스(LabCare Plus)의 자산을 인수하는 계약을 발표했습니다.
애보트 연구소(Abbott Laboratories)
개요:
애보트는 의료기기 및 헬스케어 제품을 개발하는 다국적 기업입니다. 1888년에 설립되었으며 미국 일리노이주에 본사를 두고 있습니다. 의료기기, 진단 제품, 영양 제품, 브랜드 제네릭 의약품 등을 생산 및 판매합니다.

제품 포트폴리오:
PLEX-ID: 질량 분석법과 PCR 기술을 통합한 분자 진단 기반 기술로, 다양한 미생물을 식별하고 특성화합니다.
주요 개발: 예를 들어, 2022년 5월 애보트 연구소는 자사의 Alinity m STI 검사가 미국 FDA 승인을 받았다고 발표했습니다. 이 검사는 다양한 성병을 진단하는데, 이러한 감염은 제때 치료하지 않으면 불임이나 암과 같은 심각한 건강 합병증으로 이어질 수 있습니다.
글로벌 임상 실험실 서비스 시장 보고서는 약 40개 이상의 시장 데이터 표, 45개 이상의 그림, 그리고 약 200페이지 분량의 자료를 제공합니다.

보고서 요약(영어 원문)

Clinical Laboratory Services Market Size
The Global Clinical Laboratory Services Market reached US$ 22.56 billion in 2023 and is expected to reach US$ 414.18 billion by 2031, growing at a CAGR of 6.5% during the forecast period 2024-2031.
Clinical laboratories are an integral part of the medical industry, and their services play a crucial role in detecting, diagnosing, and treating disease. Samples are collected to examine and analyze body fluids, tissues, and cells. It provides accurate results that enable physicians to make the right therapeutic decisions. It also allows physicians to start/stop or continue the course of treatment, and 70% of medical decisions are based on laboratory results. Laboratory organizations are focusing on improving their products to shorten the test duration and increase efficiency; thus, it increases the management of clinical laboratories.
Clinical Laboratory Services Market Dynamics
The increasing demand for these Clinical Laboratory Services, the rising incidence of larynx cancer, the increasing research and development expenditure and growth in novel product launches are expected to drive market growth.
The increasing novel product launches and demand for clinical laboratory services will drive market growth.
The global market for clinical laboratory services is primarily driven by the healthcare industry's demand for clinical laboratory services due to increasing chronic disorders and the rising number of product launches. Studies are being conducted on novel diagnostic assays and clinical trials in various key areas. For instance, in Jul 2022, Quest Diagnostics, a diagnostic information service provider, announced its latest molecular diagnostic test that is lab-developed to aid the diagnosis of monkeypox virus infection. They are planning to launch their CDC’s orthopoxvirus test soon.
Various latest technological advancements are taking place, and the number of novel, innovative product and service launches is increasing, leading to high demand. The latest innovations by clinical laboratories are driving the growth of the market. For instance, In Sep 2022, Qiagen announced novel additions to their NeuMoDx assay portfolio for the viruses associated with organ transplants. Its latest assays got CE-In Vitro Diagnostic mark for European Union and various other countries. The novel assays are for identifying and quantifying human herpes virus 6 and Epstein-Barr virus.
High pricing pressure faced by healthcare providers will hamper the market’s growth.
However, the pricing pressure faced by healthcare payers and providers and public concerns related to data security and privacy may hinder market progress.
COVID-19 Impact Analysis on Clinical Laboratory Services Market
The pandemic has positively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. Clinical laboratory services have experienced a boom, and the diagnosis sector has profited the most. The demand of test kits and assays are in high demand since they are used for drug research and diagnostic purposes. Various collaborations and mergers are happening worldwide, boosting the market’s growth. For instance, in Oct 2022, Labcorp, a life-sciences company, announced that they recently completed transactions with Ascension, a non-profit health system in the United States, that would lead to forming a laboratory relationship for a long period.
Clinical Laboratory Services Market Segmentation Analysis
The clinical chemistry segment is expected to grow at the fastest CAGR during the forecast period (2024-2031)
The clinical chemistry test type segment is the highest market holder in the global clinical laboratory services market. Clinical chemistry deals with analyzing blood and urine samples in which various tests related to enzymology and toxicology are performed. Various quantitative tests are performed to examine the range of substances, such as blood sugar, hormones and enzymes in the plasma. The clinical chemistry test dominates the market due to an increase in the occurrence of target diseases such as cardiovascular, diabetes, liver, kidney, and blood disorders globally. According to the WHO, in 2021, around 422 million people had diabetes, and approximately 1.5 million died yearly. Every year 17 million people die due to infectious diseases. The novel development of innovative and advanced tests is increasing market growth. For instance, Roche’s Cobas 8000 modular analyzer series is a serum work area that is a module-based solution for a broad range of in vitro clinical chemistry and immunochemistry diagnostic testing. It is developed for high-throughput labs.
Clinical Laboratory Services Market Geographical Share
North America holds the largest market share of the global clinical laboratory services market.
North America dominates the global clinical laboratory services market, primarily attributed to the increasing number of partnerships or collaborations between companies and the rising demand for clinical laboratory services due to established healthcare infrastructure, rising disposable income, and higher investment in R&D activities contribute to North America’s share growth% of test volume. Moreover, its broad base patient population and the established healthcare infrastructure and rising disposable income, and higher investment in R&D activities contribute to the growth of North America’s share. The American Cancer Society estimated that about 1.9 million new cancer cases would be registered in the U.S. in 2022, of which 609,360 people are expected to die from cancer.
Moreover, the growing number of product launches is responsible for the market’s growth. Other factors, such as the high spending of GDP on healthcare, stimulate the market’s growth. Many key developments and technological advancements are taking place based in this region. For Instance, in Jan 2022, Exact Sciences announced its acquisition of prevention genetics to expand the availability of genetic cancer testing for patients.
Clinical Laboratory Services Companies and Competitive Landscape
The clinical laboratory services market is highly competitive with local and global companies. Abbott Laboratories, Bio Reference Laboratories, Exact Sciences Corporation, Myriad Genetics, Inc, Neogenomics Inc, Quest Diagnostics Inc, Siemens Healthineer, Sonic Healthcare Limited, Laboratory Corporation of America, Synlab International GmbH and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market’s growth. For instance, in Oct 2022, Quest Diagnostic, a diagnostic information service provider, announced its agreement to acquire assets of Summa Health’s business of laboratory services LabCare Plus.
Abbott Laboratories
Overview:
Abbott is a multinational company that develops medical devices and healthcare products. It was founded in 1888 and is headquartered in Illinois, United States. Their products and services include medical devices, diagnostics, nutritional products and branded generic medicines.
Product Portfolio:
PLEX-ID: It is molecular diagnostic-based technology that integrates mass spectrometry and PCR technology and identifies and characterizes a wide range of microorganisms.
Key Development: For instance, in May 2022, Abbott Laboratories announced that its Alinity m STI Assay got cleared by U.S. FDA. This test detects various sexually transmitted infections that, if not treated on time, become serious health complications that can lead to infertility and cancer.
The global clinical laboratory services market report would provide access to approximately 40+ market data tables, 45+ figures, and 200 (approximate) pages.

상세 목차

1. Market Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The rising novel product launches
4.1.1.2. Increasing demand for clinical laboratory services
4.1.2. Restraints:
4.1.2.1. High pricing pressure faced by the healthcare provider
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces
5.2. Unmet Needs
5.3. Supply chain Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Test Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
7.1.2. Market Attractiveness Index, By Test Type
7.2. Clinical Chemistry *
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Microbiology
7.4. Serology
7.5. Hematology
7.6. Pathology
7.7. Molecular Diagnostics
7.8. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Preclinical & Clinical Trial-Related Services*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Bioanalytical & Lab Chemistry Services
8.4. Drug Discovery & Development Related Services
8.5. Cell & Gene Therapy Related Services
8.6. Others
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospital-based Labs*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Clinic-based Labs
9.4. Stand-alone Labs
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. The U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. The U.K.
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11. Competitive Landscape
11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Product Benchmarking
11.4. List of Key Companies to Watch
12. Company Profiles
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Bio Reference Laboratories
12.3. Exact Sciences Corporation
12.4. Myriad Genetics, Inc
12.5. Neogenomics Inc
12.6. Quest Diagnostics Inc
12.7. Siemens Healthineer
12.8. Sonic Healthcare Limited
12.9. Laboratory Corporation of America
12.10. Synlab International GmbH(*LIST NOT EXHAUSTIVE)
13. DataM Intelligence
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us

언급된 주요 기업들

Abbott Laboratories, Bio Reference Laboratories, Exact Sciences Corporation, Myriad Genetics, Inc, Neogenomics Inc, Quest Diagnostics Inc, Siemens Healthineer, Sonic Healthcare Limited, Laboratory Corporation of America

표 목록 (Tables)

List of Tables Table 1 Global Clinical Laboratory Services Market Value, By Test Type, 2025, 2029 & 2033 (US$ Billion)

Table 2 Global Clinical Laboratory Services Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)

Table 3 Global Clinical Laboratory Services Market Value, By Therapeutic Area, 2025, 2029 & 2033 (US$ Billion)

Table 4 Global Clinical Laboratory Services Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)

Table 5 Global Clinical Laboratory Services Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 6 Global Clinical Laboratory Services Market Value, By Test Type, 2025, 2029 & 2033 (US$ Billion)

Table 7 Global Clinical Laboratory Services Market Value, By Test Type, 2022-2033 (US$ Billion)

Table 8 Global Clinical Laboratory Services Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)

Table 9 Global Clinical Laboratory Services Market Value, By Application, 2022-2033 (US$ Billion)

Table 10 Global Clinical Laboratory Services Market Value, By Therapeutic Area, 2025, 2029 & 2033 (US$ Billion)

Table 11 Global Clinical Laboratory Services Market Value, By Therapeutic Area, 2022-2033 (US$ Billion)

Table 12 Global Clinical Laboratory Services Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)

Table 13 Global Clinical Laboratory Services Market Value, By End-User, 2022-2033 (US$ Billion)

Table 14 Global Clinical Laboratory Services Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 15 Global Clinical Laboratory Services Market Value, By Region, 2022-2033 (US$ Billion)

Table 16 North America Clinical Laboratory Services Market Value, By Test Type, 2022-2033 (US$ Billion)

Table 17 North America Clinical Laboratory Services Market Value, By Application, 2022-2033 (US$ Billion)

Table 18 North America Clinical Laboratory Services Market Value, By Therapeutic Area, 2022-2033 (US$ Billion)

Table 19 North America Clinical Laboratory Services Market Value, By End-User, 2022-2033 (US$ Billion)

Table 20 North America Clinical Laboratory Services Market Value, By Country, 2022-2033 (US$ Billion)

Table 21 Europe Clinical Laboratory Services Market Value, By Test Type, 2022-2033 (US$ Billion)

Table 22 Europe Clinical Laboratory Services Market Value, By Application, 2022-2033 (US$ Billion)

Table 23 Europe Clinical Laboratory Services Market Value, By Therapeutic Area, 2022-2033 (US$ Billion)

Table 24 Europe Clinical Laboratory Services Market Value, By End-User, 2022-2033 (US$ Billion)

Table 25 Europe Clinical Laboratory Services Market Value, By Country, 2022-2033 (US$ Billion)

Table 26 Asia-Pacific Clinical Laboratory Services Market Value, By Test Type, 2022-2033 (US$ Billion)

Table 27 Asia-Pacific Clinical Laboratory Services Market Value, By Application, 2022-2033 (US$ Billion)

Table 28 Asia-Pacific Clinical Laboratory Services Market Value, By Therapeutic Area, 2022-2033 (US$ Billion)

Table 29 Asia-Pacific Clinical Laboratory Services Market Value, By End-User, 2022-2033 (US$ Billion)

Table 30 Asia-Pacific Clinical Laboratory Services Market Value, By Country, 2022-2033 (US$ Billion)

Table 31 South America Clinical Laboratory Services Market Value, By Test Type, 2022-2033 (US$ Billion)

Table 32 South America Clinical Laboratory Services Market Value, By Application, 2022-2033 (US$ Billion)

Table 33 South America Clinical Laboratory Services Market Value, By Therapeutic Area, 2022-2033 (US$ Billion)

Table 34 South America Clinical Laboratory Services Market Value, By End-User, 2022-2033 (US$ Billion)

Table 35 South America Clinical Laboratory Services Market Value, By Country, 2022-2033 (US$ Billion)

Table 36 Middle East and Africa Clinical Laboratory Services Market Value, By Test Type, 2022-2033 (US$ Billion)

Table 37 Middle East and Africa Clinical Laboratory Services Market Value, By Application, 2022-2033 (US$ Billion)

Table 38 Middle East and Africa Clinical Laboratory Services Market Value, By Therapeutic Area, 2022-2033 (US$ Billion)

Table 39 Middle East and Africa Clinical Laboratory Services Market Value, By End-User, 2022-2033 (US$ Billion)

Table 40 Middle East and Africa Clinical Laboratory Services Market Value, By Country, 2022-2033 (US$ Billion)

Table 41 Abbott: Overview

Table 42 Abbott: Product Portfolio

Table 43 Abbott: Key Developments

Table 44 Labcorp: Overview

Table 45 Labcorp: Product Portfolio

Table 46 Labcorp: Key Developments

Table 47 OPKO Health, Inc.: Overview

Table 48 OPKO Health, Inc.: Product Portfolio

Table 49 OPKO Health, Inc.: Key Developments

Table 50 Quest Diagnostics: Overview

Table 51 Quest Diagnostics: Product Portfolio

Table 52 Quest Diagnostics: Key Developments

Table 53 NeoGenomics Laboratories: Overview

Table 54 NeoGenomics Laboratories: Product Portfolio

Table 55 NeoGenomics Laboratories: Key Developments

Table 56 Myriad Genetics, Inc.: Overview

Table 57 Myriad Genetics, Inc.: Product Portfolio

Table 58 Myriad Genetics, Inc.: Key Developments

Table 59 QIAGEN: Overview

Table 60 QIAGEN: Product Portfolio

Table 61 QIAGEN: Key Developments

Table 62 Eurofins Scientific: Overview

Table 63 Eurofins Scientific: Product Portfolio

Table 64 Eurofins Scientific: Key Developments

Table 65 Siemens Healthcare Private Limited: Overview

Table 66 Siemens Healthcare Private Limited: Product Portfolio

Table 67 Siemens Healthcare Private Limited: Key Developments

Table 68 ARUP Laboratories: Overview

Table 69 ARUP Laboratories: Product Portfolio

Table 70 ARUP Laboratories: Key Developments

그림 목록 (Figures)

List of Figures Figure 1 Global Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 2 Global Clinical Laboratory Services Market Share, By Test Type, 2024 & 2033 (%)

Figure 3 Global Clinical Laboratory Services Market Share, By Application, 2024 & 2033 (%)

Figure 4 Global Clinical Laboratory Services Market Share, By Therapeutic Area, 2024 & 2033 (%)

Figure 5 Global Clinical Laboratory Services Market Share, By End-User, 2024 & 2033 (%)

Figure 6 Global Clinical Laboratory Services Market Share, By Region, 2024 & 2033 (%)

Figure 7 Global Clinical Laboratory Services Market Y-o-Y Growth, By Test Type, 2023-2033 (%)

Figure 8 Clinical Chemistry Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 9 Hematology Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 10 Microbiology Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 11 Serology Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 12 Molecular Diagnostics Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 13 Toxicology Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 14 Pathology Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 15 Others Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 16 Global Clinical Laboratory Services Market Y-o-Y Growth, By Application, 2023-2033 (%)

Figure 17 Preclinical & Clinical Trial-Related Services Application in Global Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 18 Bioanalytical & Lab Chemistry Services Application in Global Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 19 Drug Discovery & Development Related Services Application in Global Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 20 Others Application in Global Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 21 Global Clinical Laboratory Services Market Y-o-Y Growth, By Therapeutic Area, 2023-2033 (%)

Figure 22 Oncology Therapeutic Area in Global Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 23 Cardiology Therapeutic Area in Global Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 24 Infectious Diseases Therapeutic Area in Global Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 25 Nephrology Therapeutic Area in Global Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 26 Hepatology Therapeutic Area in Global Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 27 Hematology Therapeutic Area in Global Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 28 Neurology Therapeutic Area in Global Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 29 Toxicology Therapeutic Area in Global Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 30 Others Therapeutic Area in Global Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 31 Global Clinical Laboratory Services Market Y-o-Y Growth, By End-User, 2023-2033 (%)

Figure 32 Hospital-Based Labs End-User in Global Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 33 Clinic-Based Labs End-User in Global Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 34 Central / Clinical Trial Labs End-User in Global Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 35 Others End-User in Global Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 36 Global Clinical Laboratory Services Market Y-o-Y Growth, By Region, 2023-2033 (%)

Figure 37 North America Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 38 North America Clinical Laboratory Services Market Share, By Test Type, 2024 & 2033 (%)

Figure 39 North America Clinical Laboratory Services Market Share, By Application, 2024 & 2033 (%)

Figure 40 North America Clinical Laboratory Services Market Share, By Therapeutic Area, 2024 & 2033 (%)

Figure 41 North America Clinical Laboratory Services Market Share, By End-User, 2024 & 2033 (%)

Figure 42 North America Clinical Laboratory Services Market Share, By Country, 2024 & 2033 (%)

Figure 43 Europe Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 44 Europe Clinical Laboratory Services Market Share, By Test Type, 2024 & 2033 (%)

Figure 45 Europe Clinical Laboratory Services Market Share, By Application, 2024 & 2033 (%)

Figure 46 Europe Clinical Laboratory Services Market Share, By Therapeutic Area, 2024 & 2033 (%)

Figure 47 Europe Clinical Laboratory Services Market Share, By End-User, 2024 & 2033 (%)

Figure 48 Europe Clinical Laboratory Services Market Share, By Country, 2024 & 2033 (%)

Figure 49 Asia-Pacific Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 50 Asia-Pacific Clinical Laboratory Services Market Share, By Test Type, 2024 & 2033 (%)

Figure 51 Asia-Pacific Clinical Laboratory Services Market Share, By Application, 2024 & 2033 (%)

Figure 52 Asia-Pacific Clinical Laboratory Services Market Share, By Therapeutic Area, 2024 & 2033 (%)

Figure 53 Asia-Pacific Clinical Laboratory Services Market Share, By End-User, 2024 & 2033 (%)

Figure 54 Asia-Pacific Clinical Laboratory Services Market Share, By Country, 2024 & 2033 (%)

Figure 55 South America Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 56 South America Clinical Laboratory Services Market Share, By Test Type, 2024 & 2033 (%)

Figure 57 South America Clinical Laboratory Services Market Share, By Application, 2024 & 2033 (%)

Figure 58 South America Clinical Laboratory Services Market Share, By Therapeutic Area, 2024 & 2033 (%)

Figure 59 South America Clinical Laboratory Services Market Share, By End-User, 2024 & 2033 (%)

Figure 60 South America Clinical Laboratory Services Market Share, By Country, 2024 & 2033 (%)

Figure 61 Middle East and Africa Clinical Laboratory Services Market Value, 2022-2033 (US$ Billion)

Figure 62 Middle East and Africa Clinical Laboratory Services Market Share, By Test Type, 2024 & 2033 (%)

Figure 63 Middle East and Africa Clinical Laboratory Services Market Share, By Application, 2024 & 2033 (%)

Figure 64 Middle East and Africa Clinical Laboratory Services Market Share, By Therapeutic Area, 2024 & 2033 (%)

Figure 65 Middle East and Africa Clinical Laboratory Services Market Share, By End-User, 2024 & 2033 (%)

Figure 66 Abbott: Financials

Figure 67 Labcorp: Financials

Figure 68 OPKO Health, Inc.: Financials

Figure 69 Quest Diagnostics: Financials

Figure 70 NeoGenomics Laboratories: Financials

Figure 71 Myriad Genetics, Inc.: Financials

Figure 72 QIAGEN: Financials

Figure 73 Eurofins Scientific: Financials

Figure 74 Siemens Healthcare Private Limited: Financials

Figure 75 ARUP Laboratories: Financials

글로벌 임상 검사실 서비스 시장 – 2024-2031년

Global Clinical Laboratory Services Market - 2024-2031